Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10010445 | 0.85 | — | — | |
| SCHEMBL3203754 | 0.83 | — | — | |
| SCHEMBL2019603 | 0.79 | NPC1 (0.35) | NPC1 | |
| SCHEMBL1401583 | 0.77 | NPC1 (0.48) | NPC1TSHRCA12CA1CA2 | |
| SCHEMBL291486 | 0.77 | NPC1 (0.48) | NPC1TSHRCA12CA1CA2 | |
| SCHEMBL291487 | 0.74 | — | — | |
| SCHEMBL2241578 | 0.74 | — | — | |
| SCHEMBL133211 | 0.72 | — | — | |
| SCHEMBL8293300 | 0.72 | — | — | |
| SCHEMBL868739 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9114377-B2 | High charge density structures, including carbon-based nanostructures and applications thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20150202606-A1 | HIGH CHARGE DENSITY STRUCTURES, INCLUDING CARBON-BASED NANOSTRUCTURES AND APPLICATIONS THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-07-23 | — | — | US | disclosed |
| US-8735313-B2 | High charge density structures, including carbon-based nanostructures and applications thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-05-27 | — | — | US | disclosed |
| US-8735313-B2 | High charge density structures, including carbon-based nanostructures and applications thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-05-27 | — | — | US | disclosed |
| WO-2010123482-A2 | HIGH CHARGE DENSITY STRUCTURES, INCLUDING CARBON-BASED NANOSTRUCTURES AND APPLICATIONS THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100179054-A1 | HIGH CHARGE DENSITY STRUCTURES, INCLUDING CARBON-BASED NANOSTRUCTURES AND APPLICATIONS THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-07-15 | — | — | US | disclosed |
| US-20100179054-A1 | HIGH CHARGE DENSITY STRUCTURES, INCLUDING CARBON-BASED NANOSTRUCTURES AND APPLICATIONS THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-07-15 | — | — | US | disclosed |
| EP-0138523-B1 | PENICILLIN DERIVATIVES AND PROCESS FOR PREPARING THE SAME (11111) | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1987-08-19 | — | — | EP | disclosed |
| US-4668514-A | Penicillin derivatives | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1987-05-26 | — | — | US | disclosed |
| EP-0138523-A1 | Penicillin derivatives and process for preparing the same (11111) | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1985-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179054-A1 | HIGH CHARGE DENSITY STRUCTURES, INCLUDING CARBON-BASED NANOSTRUCTURES AND APPLICATIONS THEREOF | ACP1, CA12, CNPY3 | NPC1 2896/4885TSHR 4699/4885CA12 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.